A Retinol, acetate CEP of the European Pharmacopoeia monograph is often referred to as a Retinol, acetate Certificate of Suitability (COS). The purpose of a Retinol, acetate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Retinol, acetate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Retinol, acetate to their clients by showing that a Retinol, acetate CEP has been issued for it. The manufacturer submits a Retinol, acetate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Retinol, acetate CEP holder for the record. Additionally, the data presented in the Retinol, acetate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Retinol, acetate DMF.
A Retinol, acetate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Retinol, acetate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Retinol, acetate suppliers with CEP (COS) on PharmaCompass.